NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$20.74
+1.20%
Mkt Cap $2.30B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (14 analysts)
$51.33
Range $45.00 – $58.00
Implied Upside
+147.5%
Consensus $51.33 vs current $20.74